NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Atomic AI

Atomic AI

Private
San Francisco, CaliforniaHealthcare & Life Scienceshttps://atomic.ai/

Last Round

Series A

Jan 25, 2023

Total Funding Raised

$42M

Company Overview

Atomic AI is a biotechnology company that leverages artificial intelligence and structural biology to design RNA-targeted small molecules and RNA-based medicines.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Foundation

Keywords

RNA structure predictiondrug discoveryRNA-targeted therapeuticssmall molecule therapeuticsAI-driven drug discoveryfoundation modelfrontier AI labLLMchemical mappinglarge language modelundruggable targetscomputational biologybiotech platformin silico drug designRNA therapeutics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Atomic AI Comparables

Compare Atomic AI with similar companies based on industry and business-model similarity.

Atomic AI comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ribometrix
86%
Serna Bio
86%
Wayfinder Biosciences
86%

Atomic AI Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 25, 2023

Key People

Founding team and executive leadership

Raphael Townshend

Founder CEO

Founding Team

Atomic AI Investors

Notable investors and investment history

Atomic AI investors
InvestorRounds
Potluck VenturesSeries A
Greylock PartnersSeed, Series A
Playground GlobalSeries A
Not Boring CapitalSeries A, Seed
FactorySeries A, Seed
8VCSeries A, Seed
AIX VenturesSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 1, 2026

    R&D platform featured on the cover of Science journal.

Atomic AI Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Atomic AI Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Atomic AI's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Francisco, California
Employee Range30
Year Founded2021
Last FundingJan 25, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.